RSS

Phage therapy

Vienna-based biotech company, PhagoMed Biopharma, has received more than €4 million in grants and private investments, which will be used to boost the development of alternative therapies to combat antibiotic-resistant bacteria. more

News

Biotechnology company, Pherecydes Pharma, has raised €8.7 million in a Series B round of funding, which it plans to use to support the production of phages for compassionate use in accordance with good manufacturing practuces (GMP). more

News

Phagoburn is the first clinical trial of its kind that will take place to evaluate the tolerance and effectiveness of two anti-infection bacteriophage treatments in serious burn patients more

News